The transplant diagnostic market is projected to reach USD 6.8 billion in 2028 from USD 4.4 billion in 2022 with a CAGR of 7.4% during the forecast period. The high prevalence of infectious diseases, rising government funding and initiatives for transplant diagnostic programs, technological developments for different organ transplant and initiatives by an individual to donate organs is attributing to the growth of the transplant diagnostic market.
The Transplant diagnostic market is moderately competitive, with both established companies and upcoming competitors for the same market share. As of 2021, the key players operating in the Transplant diagnosticmarket are bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), F-Hoffma-LA-Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), among others.
To know about the assumptions considered for the study download the pdf brochure
To further increase their market share in the Transplant diagnostic market, these competitors have utilized a variety of strategies, including acquisitions, agreements, partnerships, and product releases. In 2022, a higher share of the Transplant diagnostic market was held by bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories, Inc. (US)
bioMérieux SA (bioMérieux) is a provider of diagnostic solutions for medical and industrial applications. These products are used to diagnose cardiovascular diseases, targeted cancers, and infectious diseases. The company also provides various in vitro diagnostic solutions to hospitals.
bioMérieux offers sterility and quality testing solutions for the cosmetics, pharmaceutical, and food sectors. The company operates through five segments, namely, Microbiology, Molecular Biology, Immunoassays, Industrial Applications, and Other Lines. bioMérieux operates in the AST market through the Microbiology segment.
The company operates in more than 160 countries across North America, Europe, Oceania, Africa, and the Asia Pacific. It has 18 production sites and 18 R&D centers located across the globe, including the US, Brazil, China, Australia, Canada, France, and Spain. The company has 43 subsidiaries, including bioMérieux Singapore PTE LTD., bioMérieux Korea Co., Ltd. (South Korea), bioMérieux Suisse S.A. (Switzerland), bioMérieux Italy, bioMérieux Austria GmbH, bioMérieux Denmark, bioMérieux Germany, bioMérieux France, bioMérieux UK Limited, and bioMérieux Inc. (US).
Thermo Fisher Scientific
Thermo Fisher Scientific is engaged in the development, manufacturing, and marketing of analytical instruments, reagents & consumables, equipment, and software products. The company operates its businesses through four segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. The microbiology business under the company’s Specialty Diagnostics segment offers dehydrated and prepared culture media, collection and transport systems, microbiology instrumentation, and consumables to detect pathogens in blood, diagnostic, and rapid direct specimen tests, quality-control products, and associated products for microbiology laboratories.
Thermo Fisher Scientific has a strong geographic presence in more than 150 countries across North America, the Asia Pacific, Europe, and Latin America. Some of its major subsidiaries are Thermo Fisher Scientific Peru S.A., Laboratory Management Systems, Inc. (US), Open BioSystems, Inc. (US), Thermo Electron Australia Pty Limited, Lomb Scientific Pty Limited (Australia), Thermo Scientific Korea Ltd. (South Korea), Fisher Clinical Services Limited Liability Company (Russia), Fisher Clinical Services Japan K.K., and Thermo Fisher Scientific C.V. (Netherlands).
Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is engaged in the development, manufacture, and marketing of medical devices, instrument systems, and reagents. BD operates through three business segments—BD Medical, BD Life Sciences, and BD Interventional. The Life Sciences division is further divided into Diagnostic Systems, Preanalytical Systems, and Biosciences sub-divisions. The company offers transplant diagnostic products under the Diagnostic Systems segment of its Life Sciences division. The company’s end users mainly include healthcare institutions, clinical laboratories, life science researchers, and the pharmaceutical industry, among others.
BD has a presence in more than 190 countries across North America, Europe, EMA (which includes the Commonwealth of the Independent States, the Middle East, and Africa), the Asia Pacific, and Latin America. Some of its major subsidiaries are CareFusion Corporation (US), Becton Dickinson Infusion Therapy Systems Inc. (US), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), BD Holding S. de R.L. de C.V. (Mexico), Becton Dickinson Canada Inc., Becton Dickinson India Private Limited, Becton Dickinson Korea Holding, Inc. (US), Becton Dickinson Ltd. (New Zealand), Becton, Dickinson A.G. (Switzerland), Becton Dickinson Asia Limited (Hong Kong), Becton Dickinson France S.A.S., Becton Dickinson (Mauritius) Limited, and Nippon Becton Dickinson Company, Ltd. (Japan).
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (Bio-Rad) is engaged in developing, manufacturing, and supplying life sciences and clinical diagnostic tools and services. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Sciences segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company operates in the market through the Clinical Diagnostics segment.
The company has direct distribution channels in over 35 countries outside the US. It has operations across the US, Canada, Latin America, Europe, and the Pacific Rim. Some of its key subsidiaries are Bio-Rad Laboratories Pty. Limited (Australia), Bio-Rad Laboratorios Brasil Ltda. (Brazil), Bio-Rad Laboratories N.V. (Belgium), Bio-Rad Laboratories G.m.b.H. (Germany), Bio-Rad Haifa Ltd. (Israel), and Bio-Rad Laboratories K.K. (Japan).
F. Hoffmann-La Roche Ltd. (Roche) is a pharmaceutical and diagnostics company based in Switzerland. The company is engaged in the development, manufacturing, distribution, and marketing of therapeutic and diagnostic products. Roche operates through two business divisions, namely, Pharmaceuticals and Diagnostics. The Diagnostics division is further segmented into Centralized & Point of Care Solutions, Molecular Diagnostics, Tissue Diagnostics, and Diabetes Care. The company offers instruments, reagents, and software used during transplant diagnostic procedures through its Molecular Diagnostics business segment.
Roche operates in more than 100 countries, including the US, Australia, China, Denmark, Germany, India, Italy, Japan, Malaysia, Poland, Singapore, and the UK. The company has 26 manufacturing sites, including 17 pharmaceutical manufacturing sites, 7 diagnostic manufacturing sites, and 2 joint manufacturing sites. The company also has 30 R&D facilities across the globe for pharmaceutical & diagnostics. Roche distributes and sells its products across 180 countries and has over 50 subsidiaries. Its major subsidiaries include Roche Diagnostics Ltd. (UK), Roche Diagnostics Corporation (US), Hoffman La Roche Ltd. (Canada), Roche Holding Ltd. (Switzerland), Roche Diagnostics Australia Pty Ltd., Roche Diagnostics Oy (Finland), Roche Diagnostics (India) Pvt. Ltd., and Roche Diagnostics France SAS.
Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product(Instrument, Reagent, Software), Application(HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, & Region - Global Forecasts to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE